Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Scancell
Biotech
Scancell enjoys stock bounce on back of cancer vaccine data
It’s been a good week for Scancell, as investors appeared to seized on early data from a phase 2 cancer vaccine trial to send its stock up 20%.
James Waldron
Sep 19, 2023 10:55am
Immunocore lifer leaves to head research at TCR rival Scancell
Jan 21, 2019 7:59am
After $270M round, BioNTech pens TCR pact with Scancell
Jan 9, 2018 10:30am
EuroBiotech: More Articles of Note
May 11, 2017 9:19am
Scancell taps lung cancer nonprofit for trial recruitment
Jan 30, 2017 8:43am
